A thought-provoking LinkedIn post by Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester NHS Trust, has spotlighted a glaring injustice in England’s NHS-funded fertility preservation guidelines. Under current rules, a young woman diagnosed with breast cancer may find herself ineligible for fertility preservation—despite her cancer treatment endangering her fertility—if her partner already has children from a previous relationship. Ayodele rightfully asks: “In what world is that fair?”
Conditional eligibility
A woman facing life-altering cancer treatment is told that because her partner already has children, she cannot access NHS-funded fertility preservation. Ayodele argues this is not just unfair—it strips her of autonomy and an essential aspect of survivorship.
Survivorship and fertility
Fertility preservation isn’t about vanity—it’s about psychological well-being, autonomy, and hope for a future family. More women aged 20–30 are being diagnosed with breast cancer, making fertility preservation timely and essential to comprehensive care.
Policy gap
The current disconnect between oncology and reproductive medicine leaves patients in limbo. Ayodele believes policy should centre on the patient’s needs, not their relationship or their partner’s existing children.
Postcode funding lottery
Access to fertility preservation varies dramatically across England, with rules sometimes excluding women based on age, health, BMI, relationship status, or prior children. A 2020 review by the Progress Educational Trust revealed only around 30% of NHS Clinical Commissioning Groups (CCGs) offer unrestricted access for cancer patients, resulting in a postcode lottery.
Children and young people
Inequity extends to pediatric cancer care too. A UK-wide survey of 20 Principal Treatment Centres reported universal consideration for sperm banking but only 60% funded mature oocyte storage, with tissue storage often funded by charities—not the NHS.
Guideline updates
International oncology bodies, including ASCO (American Society of Clinical Oncology), have updated guidelines underscoring fertility preservation as essential for all children and reproductive-age individuals undergoing cancer therapy. Yet, NHS funding remains inconsistent.
Declining NHS IVF provision
Overall NHS funding for IVF has dropped sharply—from 40% coverage in 2012 to just 27% in 2022 and 2023—leaving many patients forced into private care.
Fertility loss is a profound side effect of cancer treatment. Restricting access based on relationship or partner’s children reinforces inequality and compounds trauma.
Studies link loss of fertility with increased emotional distress and depression among cancer survivors. Preservation strategies offer hope and improved mental health outcomes.
Fertility preservation empowers patients to make decisions about their bodies and families after cancer, irrespective of current life circumstances.
Proposed Solutions
1.National policy reform
Create unified NHS-wide criteria centred on the individual patient—regardless of their partner’s status or existing children.
2.Extend NICE and ASCO guidelines
Align NHS funding with national (NICE) and international (ASCO) standards, guaranteeing coverage for all individuals at risk of treatment-induced infertility.
3.Eliminate postcode bias
Replace locally determined criteria with nationally mandated funding, backed by standardised tariffs to ensure equal access.
4.Boost education and training
Provide comprehensive training and referral pathways so all cancer clinicians feel empowered to discuss fertility preservation options promptly.
Conclusion
Olubukola Ayodele’s passionate plea is more than righteous indignation—it’s a clarion call for systemic change. Fertility preservation is not an optional luxury—it’s a fundamental component of cancer care that significantly influences long-term mental and emotional recovery. The NHS must respond with a unified, patient-focused policy, ensuring every cancer patient has fair access to fertility-preserving treatment. This isn’t just about eggs and embryos—it’s about dignity, choice, and the right to hope.
